Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance
{{output}}
Pancreatic cancer (PC) represents a malignancy with increased mortality rate, as less than 10% of patients survive for 5 years after diagnosis. Current evolution in basic sciences has revealed promising results by decrypting genetic loci vulnerable to mutation... ...